Abstract:Background: Sepsis-induced intensive care unit-acquired weakness (ICUAW) features profound muscle atrophy and attenuated muscle regeneration related to malfunctioning satellite cells. Transforming growth factor beta (TGF-β) is involved in both processes. We uncovered an increased expression of the TGF-β receptor II (TβRII)-inhibitor SPRY domain-containing and SOCS-box protein 1 (SPSB1) in skeletal muscle of septic mice. We hypothesized that SPSB1-mediated inhibition of TβRII signalling impairs myogenic differentiation in response to inflammation. Methods: We performed gene expression analyses in skeletal muscle of cecal ligation and puncture- (CLP) and sham-operated mice, as well as vastus lateralis of critically ill and control patients. Pro-inflammatory cytokines and specific pathway inhibitors were used to quantitate Spsb1 expression in myocytes. Retroviral expression plasmids were used to investigate the effects of SPSB1 on TGF-β/TβRII signalling and myogenesis in primary and immortalized myoblasts and differentiated myotubes. For mechanistical analyses we used coimmunoprecipitation, ubiquitination, protein half-life, and protein synthesis assays. Differentiation and fusion indices were determined by immunocytochemistry, and differentiation factors were quantified by qRT-PCR and Western blot analyses. Results: SPSB1 expression was increased in skeletal muscle of ICUAW patients and septic mice. Tumour necrosis factor (TNF), interleukin-1β (IL-1β), and IL-6 increased the Spsb1 expression in C2C12 myotubes. TNF- and IL-1β-induced Spsb1 expression was mediated by NF-κB, whereas IL-6 increased the Spsb1 expression via the glycoprotein 130/JAK2/STAT3 pathway. All cytokines reduced myogenic differentiation. SPSB1 avidly interacted with TβRII, resulting in TβRII ubiquitination and destabilization. SPSB1 impaired TβRII-Akt-Myogenin signalling and diminished protein synthesis in myocytes. Overexpression of SPSB1 decreased the expression of early (Myog, Mymk, Mymx) and late (Myh1, 3, 7) differentiation-markers. As a result, myoblast fusion and myogenic differentiation were impaired. These effects were mediated by the SPRY- and SOCS-box domains of SPSB1. Co-expression of SPSB1 with Akt or Myogenin reversed the inhibitory effects of SPSB1 on protein synthesis and myogenic differentiation. Downregulation of Spsb1 by AAV9-mediated shRNA attenuated muscle weight loss and atrophy gene expression in skeletal muscle of septic mice. Conclusions: Inflammatory cytokines via their respective signalling pathways cause an increase in SPSB1 expression in myocytes and attenuate myogenic differentiation. SPSB1-mediated inhibition of TβRII-Akt-Myogenin signalling and protein synthesis contributes to a disturbed myocyte homeostasis and myogenic differentiation that occurs during inflammation.

Bradykinin mediates myogenic differentiation in murine myoblasts through the involvement of SK1/Spns2/S1P2 axis

Bradykinin regulates cell growth and migration in cultured human cardiac c-Kit+ progenitor cells.

Bradykinin‐mediated Ca2+ Signalling Regulates Cell Growth and Mobility in Human Cardiac C‐kit+ Progenitor Cells

Bradykinin, as a Reprogramming Factor, Induces Transdifferentiation of Brain Astrocytes into Neuron-like Cells

Specific phosphorylation sites underlie the stimulation of a large conductance, Ca2+-activated K+ channel by cGMP-dependent protein kinase

Bradykinin Inhibits the Transient Outward K+ Current in Mouse Schwann Cells Via the Camp/Pka Pathway

[Bradykinin Attenuates Mechanical Stress-Induced Myocardial Hypertrophy Through Inhibiting the Ca²⁺/ Calcineurin Pathway].

Nongenomic Mechanism of Glucocorticoid Inhibition of Bradykinin-Induced Calcium Influx in PC12 Cells: Possible Involvement of Protein Kinase C

Pharmacological and functional characterization of bradykinin receptors in rat cultured vascular smooth muscle cells

Regulation of Myogenesis by a Na/K-ATPase α1 Caveolin-Binding Motif

RSK2 contributes to myogenic vasoconstriction of resistance arteries by activating smooth muscle myosin and the Na+/H+ exchanger

Bradykinin Increases Cytosolic Ca2+ by Activating IP3Rs and TRPC1 Channels in Human Cardiac C-kit(+) Progenitor Cells

Regulation of PD098059 and N-acetyl-L-cysteine in bradykinin-induced proliferation in vascular smooth muscle cells

Effects of S1P on myoblastic cell contraction: possible involvement of Ca-independent mechanisms

Sphingosine kinase and sphingosine-1-phosphate regulate epithelial cell architecture by the modulation of de novo sphingolipid synthesis

Bradykinin mediates the association of collecting duct cells to form migratory colonies, through B2 receptor activation

p90RSK2, a new MLCK mediates contractility in myosin light chain kinase null smooth muscle

SPSB1-mediated inhibition of TGF-β receptor-II impairs myogenesis in inflammation

p90RSK2, a new MLCK, rescues contractility in myosin light chain kinase null smooth muscle

Modulation of bradykinin-induced intracellular Ca2+ oscillations in v-Ki-ras-transformed fibroblasts.

Sphingosine-1-phosphate enhances satellite cell activation in dystrophic muscles through a S1PR2/STAT3 signaling pathway